查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2058640

核子醫學掃描術診斷設備市場：依類型、應用、最終用戶、國家及地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測

Nuclear Imaging Equipment Market, By, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 328 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，核子醫學掃描術診斷設備市場價值將達到 34.1282 億美元，從 2026 年到 2033 年將以 7.23% 的複合年成長率成長。

核子醫學掃描術診斷設備是一種專門的醫療設備，用於檢測注射放射性示蹤劑後體內釋放的輻射。這些設備能夠產生高度精細的器官和組織3D功能及生理圖譜，進而輔助診斷和後續觀察癌症、心臟病等疾病。普華永道於2026年2月發布的《全球工業製造業展望》指出，全球醫療產業正處於歷史性的轉折點，人工智慧和先進技術正在加速推動變革性成長，並帶來更高的生產力機會。這個宏觀層面的轉變系統性地提升了精準診斷的策略優先級，而核子醫學掃描術診斷核子醫學掃描術診斷其中技術最先進、臨床影響最大的應用之一。這些結構性需求因素，加上人口、流行病學、技術和政策促進因素，預計將在預測期內推動所有主要應用領域和區域市場的持續廣泛擴張。

核子醫學掃描術診斷設備市場－市場動態

癌症和心血管疾病負擔日益加重，推動了核子醫學掃描術診斷解決方案的結構性和非週期性需求。

在全球核子醫學掃描術診斷設備市場，最顯著且結構性持續的需求推動要素是全球癌症和心血管疾病負擔的日益惡化。這兩種疾病是世界上最普遍、最致命的慢性疾病，核子醫學掃描術診斷不再只是一種診斷手段，而是醫療機構在整個工作流程中必不可少的臨床標準，涵蓋分期、治療計劃、療效評估和復發監測等各個環節。世界衛生組織（WHO）預測，全球新患者數將從2022年的約2,000萬例增加到2050年的3,500萬例以上，增幅高達77%。這主要歸因於人口老化和人口成長，以及吸菸、飲酒、肥胖和空氣污染等風險因素的增加。人口老化、臨床證據的累積和醫療保險報銷環境的改善，共同推動了癌症和心血管疾病負擔的加重，這已成為全球核子醫學掃描術診斷設備市場結構穩健且根深蒂固的需求推動要素，確保在預測期內所有核子醫學掃描術診斷設備的採購量持續成長。

核子醫學掃描術診斷設備市場－市場區隔分析：

全球核子醫學掃描術診斷設備市場按產品、應用、最終用戶和地區進行細分。

按產品類型分類，SPECT影像系統在核子醫學掃描術診斷設備市場中佔據顯著佔有率。這主要歸功於該技術無可比擬的成功應用記錄，以及廣泛的保險報銷代碼支持其在大學醫院和社區醫院的臨床應用。截至2025年，SPECT在核子醫學檢查中維持72.65%的佔有率。一個特別值得關注的市場趨勢是，GE醫療的Aurora雙探頭SPECT/CT系統於2025年5月獲得FDA 510(k)認證。該系統將核子醫學中的功能性影像與解剖影像結合，並搭載Clarify DL軟體，利用深度學習技術增強SPECT影像重建。廣泛的臨床應用、與PET相比的成本效益、完善的報銷體係以及不斷擴展的治療診斷學（治療與診斷的整合）應用，將是預測期內SPECT領域的主要成長要素。

從應用領域來看，腫瘤學在應用細分市場中佔據重要地位，並佔據最大的銷售佔有率。這主要歸功於核子醫學掃描術診斷在整個癌症治療過程中發揮的關鍵且不可替代的作用，從早期腫瘤檢測和分期到治療效果評估、復發監測，乃至診療治療診斷學治療方案的製定，無一例外。從醫療驗證的角度來看，GE醫療在美國獲得了有史以來最大的Omni Legend PET系統訂單，這主要得益於包括Vizamyl、Cerianna和Flyrcado整體的放射性藥物需求的全面成長。這標誌著一項具有里程碑意義的採購成就，量化了美國主要醫療系統對用於腫瘤診斷的下一代PET平台的信心。總體而言，腫瘤學領域深厚的市場需求、不斷擴展的治療診斷學一體化生態系統以及PET在腫瘤分期和治療效果評估方面日益加速的臨床檢驗，都將使該領域在預測期內成為市場中規模最大、創新主導最強的應用領域。

核子醫學掃描術診斷設備市場—區域洞察

北美憑藉其無與倫比的先進醫療基礎設施、全球最高密度的大學醫院和癌症治療機構、涵蓋大部分核醫學影像的完善的保險報銷體系，以及機構和社區醫院對新一代PET/CT和SPECT/CT混合系統的快速普及，在醫療創新領域佔據領先地位。西門子醫療與梅奧診所於2026年2月擴大策略夥伴關係，充分體現了北美在醫療創新領域的主導領先地位。雙方簽署了一項擴展協議，旨在加強神經退化性疾病的治療以及前列腺癌和轉移性肝腫瘤的管理。此舉將在預測期內為北美主要醫療系統帶來對先進PET/CT和SPECT/CT系統的長期穩定需求。

亞太地區已成為成長最快的區域市場，這主要得益於該地區癌症病例的快速成長、醫療基礎設施投資的加速、人均醫療支出的增加，以及中國、日本、韓國、印度和東南亞各國政府主導的醫療影像現代化計畫。為了滿足這一廣泛的區域需求，攜帶式和小型SPECT系統使農村醫療機構的普及率提高了18%。此外，基於PSMA的放射性追蹤劑的創新使攝護腺癌的影像檢查普及率提高了22%。這些應用指標表明，亞太地區正積極彌合其龐大的患者群體與長期以來不足的核子醫學掃描術診斷基礎設施之間的差距。憑藉全球成長最快的癌症患者群體、政府主導的醫療現代化計畫以及快速成長的核子醫學醫師和技術人員隊伍，亞太地區有望在預測期內成為全球核子醫學掃描術診斷設備市場中最具商業性活力和結構性成長的市場。

日本核子醫學掃描術診斷設備市場—國別分析

受人口老化和癌症患者數量增加的推動，日本核子醫學掃描術診斷設備市場正穩定成長。 PET-CT和SPECT系統的需求仍然強勁，尤其是在腫瘤科和神經科領域，因為醫院正在增加對人工智慧賦能和混合成像平台的投資，以簡化工作流程並提高診斷準確性。例如，2025年2月，日立與一家人工智慧新創公司合作，開發用於疾病早期檢測的整合成像和預測分析平台。日本的影像市場正從以設備更換為主導的模式，向以創新為驅動、專注於數位PET、治療診斷學和先進分子成像的市場轉型。

目錄

第1章：核子醫學掃描術診斷設備市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：核子醫學掃描術診斷的主要市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：核子醫學掃描術診斷設備產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：核子醫學掃描術診斷設備市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：核子醫學掃描術診斷設備市場趨勢

  • 2025年核子醫學掃描術診斷設備市場佔有率分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章核子醫學掃描術診斷設備市場：依產品分類

  • 概述
    • 基於細分市場的市佔率分析：按產品
    • SPECT影像系統
    • PET影像系統
    • 平面閃爍成像系統

第8章：核子醫學掃描術診斷設備市場：依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 腫瘤學
    • 循環系統
    • 神經病學
    • 其他用途

第9章：核子醫學掃描術診斷設備市場：依通路分類

  • 概述
    • 基於細分市場的市場佔有率分析：按分銷管道分類
    • 醫院
    • 診斷影像中心
    • 學術和研究機構
    • 其他

第10章：核子醫學掃描術診斷設備市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第11章：主要供應商分析：核子醫學掃描術診斷設備產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Canon Medical Systems Corporation
    • Mediso Ltd.
    • GE HealthCare
    • MR Solutions Ltd.
    • Digirad Corporation
    • Shimadzu Corporation
    • MILabs BV
    • SurgicEye GmbH
    • Philips Healthcare
    • PerkinElmer
    • CMR Naviscan Corporation
    • DDD-Diagnostic A/S
    • Neusoft Medical Systems
    • Siemens Healthineers
    • Others

第12章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV6618

Nuclear Imaging Equipment Market size was valued at US$ 3,412.82 Million in 2025, expanding at a CAGR of 7.23% from 2026 to 2033.

Nuclear imaging equipment consists of specialized medical devices designed to detect radiation emitted from within the body after the administration of radioactive tracers. These machines create highly detailed, 3D functional and physiological maps of organs and tissues to diagnose and monitor conditions like cancer and heart disease. According to PwC's Global Industrial Manufacturing Sector Outlook released in February 2026, the global healthcare industry sits at a historic inflection point, with AI and advanced technologies accelerating opportunities for transformative growth and productivity a macro-level shift that is systematically elevating the strategic priority of precision diagnostics, of which nuclear imaging represents one of the most technically advanced and clinically impactful expressions. Collectively, these structural demand drives demographic, epidemiological, technological, and policy-driven position the Nuclear Imaging Equipment market for sustained, broad-based expansion across every major application vertical and geographic market over the forecast period.

Nuclear Imaging Equipment Market- Market Dynamics

Rising Cancer and Cardiovascular Disease Burden Driving Structural, Non-Cyclical Demand for Nuclear Imaging Solution

The most consequential and structurally durable demand driver in the global Nuclear Imaging Equipment market is the accelerating global burden of cancer and cardiovascular disease two of the highest-incidence, highest-mortality chronic disease categories in the world - for which nuclear imaging represents not merely a diagnostic option but an institutionally mandated clinical standard of care across staging, treatment planning, therapy response assessment, and recurrence monitoring workflows. The World Health Organization projects that new global cancer cases will rise from approximately 20 million in 2022 to over 35 million by 2050 a 77% increase driven by population aging and growth, alongside increased exposure to risk factors including tobacco use, alcohol consumption, obesity, and air pollution. The cancer and cardiovascular disease burden amplified by demographic aging, expanding clinical evidence bases, and improving reimbursement environments constitutes the most structurally robust and institutionally embedded demand driver in the global Nuclear Imaging Equipment market, ensuring sustained procurement growth across the full spectrum of nuclear imaging modalities over the forecast period.

Nuclear Imaging Equipment Market- Segmentation Analysis:

The Global Nuclear Imaging Equipment Market is segmented on the basis of Product, Application, End-User, and Region.

Based on product type, the SPECT Imaging Systems segment holds the notable share in the nuclear imaging equipment market due to the modality's unmatched installed base depth and the extensive reimbursement code coverage that underpins its clinical deployment across both academic medical centers and community hospital settings. SPECT maintained 72.65% share of nuclear imaging procedure volumes in 2025. A particularly instructive market validation is GE HealthCare's May 2025 FDA 510(k) clearance for its Aurora dual-head SPECT/CT system, which integrates functional and anatomical imaging for nuclear medicine, paired with Clarify DL software that enhances SPECT image reconstruction with deep learning technology. The SPECT segment's combination of broad clinical applicability, cost-effectiveness relative to PET, established reimbursement infrastructure, and expanding theranostic applications are the key drivers during the forecast period.

Based on application, oncology represent a significant segment under the application segment, commanding the largest revenue share owing to the critical and non-substitutable role that nuclear imaging plays across the full cancer care continuum from initial tumor detection and staging, through treatment response evaluation, to recurrence monitoring and theragnostic therapy planning. From an institutional validation standpoint, GE HealthCare secured its largest-ever order of Omni Legend PET systems in the U.S. driven by increased demand across radiopharmaceutical products including Vizamyl, Cerianna, and Flyrcado - a procurement milestone that quantifies the institutional confidence that leading U.S. health systems are placing in next-generation PET platforms for oncology diagnostics. Collectively, the oncology segment's structural demand depth, expanding theragnostic ecosystem, and the accelerating clinical validation of PET in tumor staging and treatment response assessment position it as both the market's largest and most innovation-driven application vertical over the forecast period.

Nuclear Imaging Equipment Market- Geographical Insights

North America holds a prominent position, anchored by the region's unmatched combination of advanced healthcare infrastructure, the world's highest density of academic medical centers and cancer treatment facilities, robust reimbursement frameworks covering the majority of nuclear imaging procedures, and an accelerating adoption rate for next-generation hybrid PET/CT and SPECT/CT systems across both institutional and community hospital settings. The region's institutional innovation leadership is clearly evidenced by the February 2026 expansion of the Siemens Healthineers and Mayo Clinic strategic collaboration. The two organizations signed an expanded agreement to enhance care for neurodegenerative disease and the management of prostate cancer and metastatic liver tumors. A dynamic that will generate structured, long-term demand for advanced PET/CT and SPECT/CT systems across North America's leading health systems over the forecast period.

Asia-Pacific is established as the fastest-growing regional market driven by the region's rapidly expanding cancer burden, accelerating healthcare infrastructure investment, rising per-capita healthcare expenditure, and government-backed programs to modernize medical imaging capabilities across China, Japan, South Korea, India, and Southeast Asia. Reinforcing the broader regional demand picture, portable and compact SPECT systems have expanded access in rural healthcare facilities by 18%, while PSMA-based radiotracer innovations have increased prostate cancer imaging volumes by 22% deployment metrics that quantify how the Asia-Pacific region is actively bridging the access gap between its large patient population and its historically underserved nuclear imaging infrastructure. Asia-Pacific's combination of the world's fastest-growing cancer patient population, government-backed healthcare modernization programs, and rapidly expanding nuclear medicine physician and technologist workforce collectively positions the region as the most commercially dynamic and structurally consequential growth market in the global Nuclear Imaging Equipment landscape over the forecast period.

Japan Nuclear Imaging Equipment Market - Country Analysis

Japan's nuclear imaging equipment market is witnessing steady growth, supported by the country's aging population and rising cancer burden. The country continues to see strong demand for PET-CT and SPECT systems, particularly in oncology and neurology applications, as hospitals increasingly invest in AI-enabled and hybrid imaging platforms to improve workflow efficiency and diagnostic precision. For instance, in February 2025, Hitachi's formed a strategic alliance with an AI startup to develop integrated imaging and predictive analytics platforms for early disease detection. Japan is transitioning from a replacement-driven imaging market toward a more innovation-led environment focused on digital PET, theranostics, and advanced molecular imaging.

Nuclear Imaging Equipment Market- Competitive Landscape:

The global Nuclear Imaging Equipment market is characterized by a highly consolidated competitive structure, dominated by a small number of large, globally diversified medical technology companies. The prominent companies operating in the global Nuclear Imaging Equipment market include Siemens Healthineers AG, GE HealthCare, Koninklijke Philips N.V., Canon Medical Systems Corporation, and Mediso Medical Imaging Systems. Siemens Healthineers and GE HealthCare dominate the market with their extensive portfolios of imaging systems including hybrid PET/CT and SPECT/CT scanners, while Philips Healthcare and Canon Medical Systems also contribute significantly with high-quality imaging devices that provide enhanced resolution and greater diagnostic precision.

Recent Developments:

In November 2025, Siemens Healthineers rebranded its PET radiopharmaceutical companies PETNET Solutions Inc. and Advanced Accelerator Applications Molecular Imaging under the unified Siemens Healthineers corporate identity, effective immediately - a structural reorganization that carries profound implications for the competitive dynamics of the global nuclear imaging market.

In May 2025, GE HealthCare obtained FDA 510(k) clearance for the Aurora dual-head SPECT/CT system and Clarify DL software - with the system integrating functional and anatomical imaging for nuclear medicine, while the Clarify DL software enhances SPECT image reconstruction with deep learning technology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Canon Medical Systems Corporation
  • Mediso Ltd.
  • GE HealthCare
  • MR Solutions Ltd.
  • Digirad Corporation
  • Shimadzu Corporation
  • MILabs B.V.
  • SurgicEye GmbH
  • Philips Healthcare
  • PerkinElmer
  • CMR Naviscan Corporation
  • DDD-Diagnostic A/S
  • Neusoft Medical Systems
  • Siemens Healthineers
  • Others

GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033

  • SPECT Imaging Systems
  • PET Imaging Systems
  • Planar Scintigraphy Imaging Systems

GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Oncology
  • Cardiology
  • Neurology
  • Other Applications

GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY END-USER- MARKET ANALYSIS, 2020 - 2033

  • Hospitals
  • Imaging Centers
  • Academic & Research Centers
  • Others

GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Nuclear Imaging Equipment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Nuclear Imaging Equipment Market Snippet by Product
    • 2.1.2. Nuclear Imaging Equipment Market Snippet by Application
    • 2.1.3. Nuclear Imaging Equipment Market Snippet by End-User
    • 2.1.4. Nuclear Imaging Equipment Market Snippet by Country
    • 2.1.5. Nuclear Imaging Equipment Market Snippet by Region
  • 2.2. Competitive Insights

3. Nuclear Imaging Equipment Key Market Trends

  • 3.1. Nuclear Imaging Equipment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Nuclear Imaging Equipment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Nuclear Imaging Equipment Market Opportunities
  • 3.4. Nuclear Imaging Equipment Market Future Trends

4. Nuclear Imaging Equipment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Nuclear Imaging Equipment Market : Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Nuclear Imaging Equipment Market Landscape

  • 6.1. Nuclear Imaging Equipment Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Nuclear Imaging Equipment Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
    • 7.1.2. SPECT Imaging Systems
    • 7.1.3. PET Imaging Systems
    • 7.1.4. Planar Scintigraphy Imaging Systems

8. Nuclear Imaging Equipment Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Oncology
    • 8.1.3. Cardiology
    • 8.1.4. Neurology
    • 8.1.5. Other Applications

9. Nuclear Imaging Equipment Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2025 & 2033 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Imaging Centers
    • 9.1.4. Academic & Research Centers
    • 9.1.5. Others

10. Nuclear Imaging Equipment Market - By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Nuclear Imaging Equipment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Nuclear Imaging Equipment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Nuclear Imaging Equipment Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Nuclear Imaging Equipment Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Nuclear Imaging Equipment Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Nuclear Imaging Equipment Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Canon Medical Systems Corporation
    • 11.2.2. Mediso Ltd.
    • 11.2.3. GE HealthCare
    • 11.2.4. MR Solutions Ltd.
    • 11.2.5. Digirad Corporation
    • 11.2.6. Shimadzu Corporation
    • 11.2.7. MILabs B.V.
    • 11.2.8. SurgicEye GmbH
    • 11.2.9. Philips Healthcare
    • 11.2.10. PerkinElmer
    • 11.2.11. CMR Naviscan Corporation
    • 11.2.12. DDD-Diagnostic A/S
    • 11.2.13. Neusoft Medical Systems
    • 11.2.14. Siemens Healthineers
    • 11.2.15. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us